Progress in Rheumatology

1. Strategies to Manage Difficult-to-treat Rheumatoid Arthritis
2. Choosing between Targeted Therapies for Rheumatoid Arthritis
3. Recognition and Management of Enthesitis in Spondyloarthritides
4. Targeted Therapies for Spondyloarthritides
5. Newer Drugs and Therapies in Systemic Lupus Erythematosus
6. Sjogren's Beyond Sicca and Kidneys
7. Difficult to Treat Psoriatic Arthritis
8. Addressing Unmet Needs in Connective Tissue Diseases Associated with Interstitial Lung Disease Management
9. Newer Drugs for the Management of Pulmonary Hypertension
10. Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in 2025
11. Harnessing Information for Better Management of Myositis
12. Antidiabetic and Antiobesity Drugs in Osteoarthritis: Hype or Hope?
13. Immunoglobulin G4-related Disease: A Contemporary Review of a Multifaceted Fibroinflammatory Syndrome
14. Fertility Preservation Strategies and the Rheumatologist
15. Chimeric Antigen Receptor-T Cell Therapy in Autoimmune Rheumatic Diseases
16. Chronic Urticaria: Pathogenesis and Clinical Paradigms Suggesting a Systemic Autoimmune Disease
17. Artificial Intelligence in Rheumatology: Where are We?

Bimlesh Dhar Pandey MD MRCP SCE Rheumatology (RCP, UK)
Director, Department of Rheumatology, Fortis Hospital, Noida, Uttar Pradesh, India
Neeraj Jain DNB FACR FRCP (Edinburgh)
Professor, GRIPMER; Vice Chairman and Senior Consultant, Rheumatologist, Department of Rheumatology and Clinical Immunology, Sir Ganga Ram Hospital, New Delhi, India